Sigyn Therapeutics, Inc.
SIGY· OTC
SIGYSigyn Therapeutics, Inc.
Quarterly figures for Sigyn Therapeutics, Inc., with source filings when available.
44 quarters. Sep 30, 2014 to Sep 30, 2025. USD.
Sigyn Therapeutics, Inc. has filed its 10-Q within 44 to 67 days of period end across its last 8 quarters. The 10-K runs 51 to 105 days.
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | |||||||||
| Q3 2025 | Sep 30, 2025 | — | Nov 14, 2025 | 45 d | 10-Q | — | — | -$0.36 | |
| Q2 2025 | Jun 30, 2025 | — | Sep 5, 2025 | 67 d | 10-Q | — | — | -$0.90 | |
| Q1 2025 | Mar 31, 2025 | — | May 20, 2025 | 50 d | 10-Q | — | — | -$0.42 | |
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Apr 15, 2025 | 105 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 19, 2024 | 50 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Feb 20, 2024 | 51 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 14, 2023 | 45 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 31, 2023 | 90 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Mar 21, 2022 | 80 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | ||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Apr 6, 2021 | 96 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 9, 2020 | 40 d | 10-Q | ||||
| FY 2019 | |||||||||
| Q4 2019 | Dec 31, 2019 | — | Mar 30, 2020 | 90 d | 10-K | $5.34K | — | $0.00 | |
| Q3 2019 | Sep 30, 2019 | — | Nov 12, 2019 | 43 d | |||||
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | Apr 1, 2019 | 91 d | 10-K | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | 45 d | 10-Q | ||||
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | Apr 2, 2018 | 92 d | 10-K | — | — | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 13, 2017 | 44 d | 10-Q | ||||
| FY 2016 | |||||||||
| Q3 2016 | Sep 30, 2016 | — | Nov 14, 2016 | 45 d | 10-Q | — | — | -$0.01 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 4, 2016 | 35 d | 10-Q | ||||
| FY 2015 | |||||||||
| Q4 2015derived | Dec 31, 2015 | — | Mar 30, 2016 | 90 d | 10-K | $0.00 | — | — | |
| Q3 2015 | Sep 30, 2015 | — | Dec 3, 2015 | 64 d | |||||
| FY 2014 | |||||||||
| Q4 2014derived | Dec 31, 2014 | — | — | — | — | — | — | — | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | $13.48K | — | $0.00 | |
| — |
| — |
| -$0.94 |
| Q2 2024 | Jun 30, 2024 | — | Aug 19, 2024 | 50 d | 10-Q | — | — | -$0.70 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 14, 2024 | 44 d | 10-Q | — | — | -$0.62 |
|---|
| — |
| — |
| -$0.82 |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | — | — | -$0.67 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | — | — | -$1.39 |
|---|
| — |
| — |
| -$0.02 |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | — | — | -$0.02 |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 13, 2022 | 43 d | 10-Q | — | — | — |
|---|
| — |
| — |
| -$0.02 |
| Q2 2021 | Jun 30, 2021 | — | Aug 16, 2021 | 47 d | 10-Q | — | — | -$0.02 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | — | — | -$0.01 |
|---|
| $3.83K |
| −88.1% |
| -$0.59 |
| Q2 2020 | Jun 30, 2020 | — | Aug 7, 2020 | 38 d | 10-Q | $0.00 | −100.0% | -$0.52 |
|---|
| Q1 2020 | Mar 31, 2020 | — | May 15, 2020 | 45 d | 10-Q | $756.00 | −98.2% | -$0.50 |
|---|
| 10-Q |
| $32.10K |
| −64.5% |
| -$0.26 |
| Q2 2019 | Jun 30, 2019 | — | Aug 5, 2019 | 36 d | 10-Q | $64.33K | — | $0.00 |
|---|
| Q1 2019 | Mar 31, 2019 | — | Apr 19, 2019 | 19 d | 10-Q | $41.55K | — | $0.00 |
|---|
| $90.45K |
| −64.7% |
| -$0.01 |
| Q2 2018 | Jun 30, 2018 | — | Aug 13, 2018 | 44 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2018 | Mar 31, 2018 | — | May 15, 2018 | 45 d | 10-Q | — | — | -$0.01 |
|---|
| $255.98K |
| — |
| -$0.03 |
| Q2 2017 | Jun 30, 2017 | — | Aug 14, 2017 | 45 d | 10-Q | $432.53K | — | -$0.02 |
|---|
| Q1 2017 | Mar 31, 2017 | — | Jun 2, 2017 | 63 d | 10-Q | $268.93K | — | -$0.01 |
|---|
| — |
| — |
| -$0.03 |
| Q1 2016 | Mar 31, 2016 | — | May 9, 2016 | 39 d | 10-Q | — | — | -$0.02 |
|---|
| 10-Q |
| — |
| — |
| -$0.03 |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $18.44K | — | -$0.02 |
|---|
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $10.77K | — | -$0.01 |
|---|
